First and/or second-line treatment (rescue therapy) of viral and malignant diseases include: Chronic myelogenous leukemia (CML), hairy cell leukemia, hepatitis B, hepatitis C, malignant melanoma, and renal cell carcinoma
Adults: SubQ: High-risk malignant melanoma (after resection and 2 doses of dacarbazine): 3 million international units 3 times per week for 6 months
Product available in various countries; not currently available in the US
Injection, solution: 6 int. units/mL (1 mL) [contains albumin]
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟